Ganciclovir
CS Crumpacker - New England Journal of Medicine, 1996 - Mass Medical Soc
… ganciclovir's mechanisms of action and resistance and discuss the clinical effectiveness of
intravenous and oral ganciclovir… of ganciclovir and acyclovir, large amounts of ganciclovir …
intravenous and oral ganciclovir… of ganciclovir and acyclovir, large amounts of ganciclovir …
Ganciclovir
AA Al-Badr, TDS Ajarim - Profiles of drug substances, excipients and …, 2018 - Elsevier
… Ganciclovir is given by intravenous infusion as the sodium salt but doses are expressed in
terms ganciclovir 54.3 mg of ganciclovir sodium is equivalent to about 50 mg of ganciclovir. …
terms ganciclovir 54.3 mg of ganciclovir sodium is equivalent to about 50 mg of ganciclovir. …
Antiviral activity and mechanism of action of ganciclovir
T Matthews, R Boehme - Reviews of infectious diseases, 1988 - academic.oup.com
… ganciclovir-MP- is rate-limiting for the synthesis of ganciclovir-TP. Subsequent phosphorylating
reactions-producing ganciclovir-DP and ganciclovir… significant amounts of ganciclovir-MP …
reactions-producing ganciclovir-DP and ganciclovir… significant amounts of ganciclovir-MP …
Ganciclovir: a review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections
D Faulds, RC Heel - Drugs, 1990 - Springer
… maintenance therapy to prevent disease progression, as ganciclovir (like other antivirals) …
frequently during ganciclovir administration but are usually reversible. Ganciclovir has not …
frequently during ganciclovir administration but are usually reversible. Ganciclovir has not …
Ganciclovir for the treatment and suppression of serious infections caused by cytomegalovirus
…, SA Spector, Ganciclovir Study Group - The American journal of …, 1987 - Elsevier
Ganciclovir is a congener of acyclovir with in vitro activity against cytomegalovirus. Ninety-seven
patients with the acquired immune deficiency syndrome (AIDS) and a serious …
patients with the acquired immune deficiency syndrome (AIDS) and a serious …
Ganciclovir: an update of its therapeutic use in cytomegalovirus infection
A Markham, D Faulds - Drugs, 1994 - Springer
… Direct comparisons between ganciclovir and foscarnet in this indication are few… ganciclovir;
maintenance therapy does not appear to be required in these latter 2 indications. Ganciclovir …
maintenance therapy does not appear to be required in these latter 2 indications. Ganciclovir …
Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant
…, Roche Ganciclovir Study Group - … England Journal of …, 1999 - Mass Medical Soc
… in the group assigned to the ganciclovir implant plus placebo, as … ganciclovir implant plus
oral ganciclovir (P=0.002) and 19.6 percent in the group assigned to intravenous ganciclovir …
oral ganciclovir (P=0.002) and 19.6 percent in the group assigned to intravenous ganciclovir …
Pharmacokinetic, safety, and antiviral profiles of oral ganciclovir in persons infected with human immunodeficiency virus: a phase I/II study
SA Spector, DF Busch, S Follansbee… - Journal of Infectious …, 1995 - academic.oup.com
A phase I/II study evaluated the pharmacokinetics, tolerability, and antiviral activity of oral
ganciclovir in persons infected with human immunodeficiency virus (HIV). Oral bioavailability …
ganciclovir in persons infected with human immunodeficiency virus (HIV). Oral bioavailability …
Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study
RJ Whitley, G Cloud, W Gruber… - Journal of Infectious …, 1997 - academic.oup.com
… A phase II evaluation was done of ganciclovir for the … Five additional babies received
ganciclovir on a compassionate plea … safety evaluation of ganciclovir for the treatment of symptom…
ganciclovir on a compassionate plea … safety evaluation of ganciclovir for the treatment of symptom…
Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant
…, Ganciclovir Implant Study Group - … England Journal of …, 1997 - Mass Medical Soc
… with intravenous ganciclovir as among those treated with a ganciclovir … ganciclovir than
with a ganciclovir implant (risk ratio, 0.5; P = 0.19). Patients treated with intravenous ganciclovir …
with a ganciclovir implant (risk ratio, 0.5; P = 0.19). Patients treated with intravenous ganciclovir …